Recently Featured

Defossilization Needs to Be Critical Target in a Sustainability Program

April 8, 2026
Crude oil prices have surged to levels not seen since 2022, when geopolitical tensions escalated, impacting global markets significantly. This spike, with prices hovering around $99 per barrel, underscores the urgent need for the bioprocessing industry to address its reliance on fossil fuels. A recent report from F. Hoffmann-La Roche highlights that up to 60%…

Peptonics Solves Cell Culture Defoaming Debacle

April 8, 2026
Advances in surfactants are transforming the landscape of mammalian cell cultures used for producing monoclonal antibodies and viral vectors. Peptonic ih-T1010, a new peptide and peptoid mimetic of poloxamers, is gaining traction as a robust alternative to conventional poloxamer surfactants. Stefano Menegatti, PhD, from North Carolina State University, emphasizes that Peptonic ih-T1010 offers biopharmaceutical manufacturers…

Guidance on Environmental Risk Assessments for Medicinal Products Released in the UK

April 8, 2026
The UK has issued new guidance outlining the expectations for environmental risk assessments (ERAs) related to medicinal products. This regulatory framework aims to enhance the understanding of how pharmaceuticals impact the environment, ensuring that potential risks are adequately evaluated before market entry. As the pharmaceutical industry faces increasing scrutiny regarding its environmental footprint, this guidance…

Engineering Biology to Fight Cancer

April 7, 2026
Recent advancements in preclinical research are paving the way for innovative therapies aimed at combating the most challenging solid tumors. As next-generation therapies progress through clinical trials, the accumulation of patient data is creating a valuable feedback loop that informs further development and optimization of these treatments. Cancer, particularly solid tumors, presents a complex landscape…

Ongoing Cases